mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.06 |